Pregnancy Outcome in Recurrent Aborters is Not Influenced by Chlamydia IgA and/or G

Authors


Address reprint requests to Mayumi Sugiura-Ogasawara, Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 4678601, Japan.
E-mail: og.mym@med.nagoya-cu.ac.jp

Abstract

Problem:  It is unclear whether chlamydia infection influences the miscarriage rate and immunological factors in patients with recurrent miscarriage.

Method of study:  Chlamydia DNA, IgA and IgG to Chlamydia trachomatis, natural killer cell activity, complement 3 (C3), C4, hemolytic complement, antinuclear antibodies, antiphospholipid antibodies, prolactin, activated partial thromboplastin time, prothrombin time and fibrinogen were examined in 504 patients with a history of two or more consecutive first-trimester miscarriages. Subsequent pregnancy outcomes were compared between cases with and without antibodies to C. trachomatis.

Results:  Totals of 10 of 30 and 48 of 201 patients receiving no medication miscarried subsequently with and without chlamydia infection. Chlamydia IgA and/or IgG were associated with a high level of C3 but not other immunological and coagulatory parameters.

Conclusion:  Antibodies to C. trachomatis do not influence subsequent pregnancy outcome in patients with a history of recurrent miscarriage.

Ancillary